Provided by Tiger Trade Technology Pte. Ltd.

Orchestra BioMed

4.90
-0.1400-2.78%
Volume:79.19K
Turnover:395.57K
Market Cap:293.42M
PE:-4.90
High:5.35
Open:5.02
Low:4.88
Close:5.04
52wk High:5.78
52wk Low:2.20
Shares:59.88M
Float Shares:33.00M
Volume Ratio:1.29
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9995
EPS(LYR):-1.1091
ROE:-397.30%
ROA:-45.73%
PB:15.18
PE(LYR):-4.42

Loading ...

Orchestra Biomed Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Orchestra BioMed Hldgs Q1 EPS $(0.33) Beats $(0.41) Estimate, Sales $110.000K Miss $190.750K Estimate

Benzinga Earnings
·
May 13

Orchestra BioMed Q1 revenue falls and misses estimates

Reuters
·
May 13

BRIEF-Orchestra BioMed Q1 EPS USD -0.33

Reuters
·
May 13

Orchestra Biomed Q1 EPS USD -0.33

THOMSON REUTERS
·
May 13

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

GlobeNewswire
·
May 13

Press Release: Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

Dow Jones
·
May 13

Orchestra BioMed Q1 net loss widens 10% to $20.7 million; revenue drops 87% to $110,000

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Orchestra BioMed Holdings (OBIO)

TIPRANKS
·
May 12

Orchestra BioMed gives clinical, regulatory update on BACKBEAT trial timeline

TIPRANKS
·
May 12

Orchestra BioMed targets BACKBEAT trial enrollment completion by end-Q3 2026

Reuters
·
May 12

U.S. Earnings Preview: After Market Close May 8

Dow Jones
·
May 09

Orchestra BioMed receives $15M payment from Ligand

TIPRANKS
·
May 07

Press Release: Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

Dow Jones
·
May 06

Orchestra Biomed Receives $20 Million Payment From Medtronic Under Previously Announced Financing Agreement

THOMSON REUTERS
·
May 06

Orchestra Biomed Holdings Inc expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
May 02

Orchestra granted additional breakthrough device designation for AVIM therapy

TIPRANKS
·
May 01

Orchestra BioMed wins FDA Breakthrough Device designation for AVIM hypertension therapy

Reuters
·
Apr 30

FDA Grants Orchestra Biomed Additional Breakthrough Device Designation for Avim Therapy

THOMSON REUTERS
·
Apr 30

RTW Investments reports disposal of 32 Orchestra BioMed shares for $132.16

Reuters
·
Apr 30